Literature DB >> 8054822

Recurrent pulmonary metastases from benign giant cell tumors of the bone: report of two cases and analysis of nuclear DNA content by flow cytometry.

I Takanami1, T Imamura, N Morota, S Kodaira.   

Abstract

It is impossible to predict the biological characteristics of benign giant cell tumors of the bone (BGCTB) from light microscopic findings. About 2% of patients with BGCTB develop pulmonary metastases and we encountered two such patients, both of whom underwent several pulmonary resections. The nuclear DNA content of the primary lesion, the locally recurrent lesion, and the pulmonary metastatic lesions were determined by flow cytometry. The tumors from both patients exhibited a diploid pattern without any of the biological characteristics of BGCTB such as latent activity or metastasis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8054822     DOI: 10.1007/bf01427045

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  10 in total

1.  Treatment of giant-cell tumor of bone.

Authors:  E W JOHNSON; D C DAHLIN
Journal:  J Bone Joint Surg Am       Date:  1959-07       Impact factor: 5.284

2.  "Benign" giant cell tumor of bone metastasizing to lung.

Authors:  A A Gresen; D C Dahlin; L F Peterson; W S Payne
Journal:  Ann Thorac Surg       Date:  1973-11       Impact factor: 4.330

3.  Giant-cell tumor of bone. An analysis of two hundred and eighteen cases.

Authors:  R R Goldenberg; C J Campbell; M Bonfiglio
Journal:  J Bone Joint Surg Am       Date:  1970-06       Impact factor: 5.284

4.  Giant-cell tumor of bone with pulmonary metastases.

Authors:  F Bertoni; D Present; W F Enneking
Journal:  J Bone Joint Surg Am       Date:  1985-07       Impact factor: 5.284

5.  Benign giant-cell tumours of bone with pulmonary metastases and favourable prognosis. Report on two cases and review of the literature.

Authors:  D Vanel; G Contesso; G Rebibo; B Zafrani; J Masselot
Journal:  Skeletal Radiol       Date:  1983       Impact factor: 2.199

Review 6.  Flow cytometry, cellular DNA content, and prognosis in human malignancy.

Authors:  D E Merkel; L G Dressler; W L McGuire
Journal:  J Clin Oncol       Date:  1987-10       Impact factor: 44.544

7.  Metastases from histologically benign giant-cell tumor of bone.

Authors:  M G Rock; D J Pritchard; K K Unni
Journal:  J Bone Joint Surg Am       Date:  1984-02       Impact factor: 5.284

8.  Biological characterization of human bone tumors. VII. Detection of malignancy in a giant cell tumor of bone by flow cytometric DNA-analysis.

Authors:  W Mellin; A Roessner; E Grundmann; B Wörmann; W Hiddemann; M Immenkamp
Journal:  Pathol Res Pract       Date:  1985-12       Impact factor: 3.250

9.  Benign metastasizing giant cell tumors of bone. A DNA flow cytometric study.

Authors:  M Ladanyi; F Traganos; A G Huvos
Journal:  Cancer       Date:  1989-10-01       Impact factor: 6.860

Review 10.  Benign metastasizing giant-cell tumor of bone. Report of three cases and review of the literature.

Authors:  W J Maloney; L M Vaughan; H H Jones; J Ross; D A Nagel
Journal:  Clin Orthop Relat Res       Date:  1989-06       Impact factor: 4.176

  10 in total
  1 in total

1.  Metastatic potential of an aneurysmal bone cyst.

Authors:  Addy C M van de Luijtgaarden; Rene P H Veth; Piet J Slootweg; Pauline M Wijers-Koster; Leo J Schultze Kool; Judith V M G Bovee; Winette T A van der Graaf
Journal:  Virchows Arch       Date:  2009-10-17       Impact factor: 4.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.